Presentation in patients with angiographically documented coronary artery disease and type II diabetes mellitus (from the BARI 2D clinical trial)

American Journal of Cardiology

Volumn 109, Issue 1, 2012, Pages 36-41

  Krishnaswami, Ashok ^a   Hardison, Regina ^b   Nesto, Richard W ^c   Sobel, Burton ^d  

^a KAISER PERMANENTE MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

^d Fibrinolytic and Coagulation Core Laboratory   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; CLINICAL ASSESSMENT; CLINICAL FEATURE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE REVASCULARIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL;

AGED; BLOOD GLUCOSE; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MIDDLE AGED; MYOCARDIAL REVASCULARIZATION; PROGNOSIS; TIME FACTORS;

EID: 83555168190     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2011.08.004     Document Type: Article

References (16)

1. R.L. Frye, P. August, M.M. Brooks, R.M. Hardison, S.F. Kelsey, J.M. MacGregor, T.J. Orchard, B.R. Chaitman, S.M. Genuth, S.H. Goldberg, M.A. Hlatky, T.L. Jones, M.E. Molitch, R.W. Nesto, E.Y. Sako, B.E. Sobel A randomized trial of therapies for type 2 diabetes and coronary artery disease N Engl J Med 24 2009 2503 2515
2. Baseline characteristics of patients with diabetes and coronary artery disease enrolled in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial Am Heart J 3 2008 528 536
3. M.F. Magee, W.L. Isley Rationale, design, and methods for glycemic control in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial Am J Cardiol 97 suppl 2006 20G 30G
4. G.W. Barsness, B.J. Gersh, M.M. Brooks, R.L. Frye Rationale for the revascularization arm of the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial Am J Cardiol 97 suppl 2006 31G 40G
5. S.M. Alderman EL The angiographic definitions of the Bypass Angioplasty Revascularization Investigation Coronary Artery Disease 3 1992 1189 1207
6. A. Abidov, A. Rozanski, R. Hachamovitch, S.W. Hayes, F. Aboul-Enein, I. Cohen, J.D. Friedman, G. Germano, D.S. Berman Prognostic significance of dyspnea in patients referred for cardiac stress testing N Engl J Med 18 2005 1889 1898 (Pubitemid 41565954)
7. R.W. Nesto, R.T. Phillips, K.G. Kett, T. Hill, E. Perper, E. Young, O.S. Leland Jr Angina and exertional myocardial ischemia in diabetic and nondiabetic patients: assessment by exercise thallium scintigraphy Ann Intern Med 2 1988 170 175 (Pubitemid 18081187)
8. American Thoracic Society Dyspnea Mechanisms, assessment, and management: a consensus statement Am J Respir Crit Care Med 1 1999 321 340
9. ADHERE Scientific Advisory Committee Acute Decompensated Heart Failure National Registry (ADHERE©) Core Module Q1 2006 Final Cumulative National Benchmark Report 2006 Scios Sunnyvale, California
10. C.M. O'Connor, W.G. Stough, D.S. Gallup, V. Hasselblad, M. Gheorghiade Demographics, clinical characteristics, and outcomes of patients hospitalized for decompensated heart failure: observations from the IMPACT-HF registry J Card Fail 3 2005 200 205 (Pubitemid 40462423)
11. H. Yki-Jarvinen Thiazolidinediones N Engl J Med 11 2004 1106 1118
12. R.W. Nesto, D. Bell, R.O. Bonow, V. Fonseca, S.M. Grundy, E.S. Horton, M. Le Winter, D. Porte, C.F. Semenkovich, S. Smith, L.H. Young, R. Kahn Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association October 7 2003 Circulation 23 2003 2941 2948 (Pubitemid 37517824)
13. M.J. Zellweger, R. Hachamovitch, X. Kang, S.W. Hayes, J.D. Friedman, G. Germano, M.E. Pfisterer, D.S. Berman Prognostic relevance of symptoms versus objective evidence of coronary artery disease in diabetic patients Eur Heart J 7 2004 543 550 (Pubitemid 38478546)
14. D.A. Gorog Prognostic value of plasma fibrinolysis activation markers in cardiovascular disease J Am Coll Cardiol 24 2010 2701 2709
15. F.B. Smith, F.G. Fowkes, A. Rumley, A.J. Lee, G.D. Lowe, C.M. Hau Tissue plasminogen activator and leucocyte elastase as predictors of cardiovascular events in subjects with angina pectoris: Edinburgh Artery Study Eur Heart J 19 2000 1607 1613
16. B.E. Sobel Ancillary studies in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial: synergies and opportunities Am J Cardiol 12A suppl 2006 53G 58G